Deferred Tax Assets, Valuation Allowance of Climb Bio, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Climb Bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Climb Bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $39,368,000, a 38% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Climb Bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $39,368,000 +$10,876,000 +38% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q4 2024 $28,492,000 +$7,636,000 +37% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q4 2023 $20,856,000 +$4,097,000 +24% 31 Dec 2023 10-K 05 Mar 2026 2025 FY
Q4 2022 $16,759,000 +$6,088,000 +57% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q4 2021 $10,671,000 +$6,047,000 +131% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q4 2020 $4,624,000 31 Dec 2020 10-K 07 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.